Geode Capital Management, LLC Adaptive Biotechnologies Corp Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,661,878 shares of ADPT stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,661,878

Previous 2,682,328 0.76%

Holding current value

$17 Million

Previous $9.71 Million 40.35%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.37 - $5.12 $68,916 - $104,704	-20,450 Reduced 0.76%	2,661,878 $13.6 Million
Q2 2024 Aug 09, 2024	BUY	$2.34 - $3.96 $241,492 - $408,679	103,202 Added 4.0%	2,682,328 $9.71 Million
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $159,793 - $266,323	55,484 Added 2.2%	2,579,126 $8.28 Million
Q4 2023 Feb 13, 2024	BUY	$3.46 - $5.33 $372,859 - $574,376	107,763 Added 4.46%	2,523,642 $12.4 Million
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $655,312 - $1.09 Million	129,253 Added 5.65%	2,415,879 $13.2 Million
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $437,298 - $620,271	70,646 Added 3.19%	2,286,626 $15.3 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $548,628 - $711,107	70,337 Added 3.28%	2,215,980 $19.6 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $597,610 - $891,643	95,465 Added 4.66%	2,145,643 $16.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $128,654 - $250,777	19,793 Added 0.97%	2,050,178 $14.6 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $3.94 Million - $9.07 Million	615,970 Added 43.55%	2,030,385 $16.4 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $242,343 - $692,068	-23,947 Reduced 1.66%	1,414,415 $19.6 Million
Q4 2021 Feb 11, 2022	BUY	$25.17 - $36.85 $1.17 Million - $1.71 Million	46,431 Added 3.34%	1,438,362 $40.4 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $6.69 Million - $8.88 Million	222,728 Added 19.05%	1,391,931 $47.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $2.79 Million - $3.86 Million	86,484 Added 7.99%	1,169,203 $47.8 Million
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $1.74 Million - $3.17 Million	46,785 Added 4.52%	1,082,719 $43.6 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $2.48 Million - $3.61 Million	55,124 Added 5.62%	1,035,934 $61.3 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $15.9 Million - $21.7 Million	444,678 Added 82.94%	980,810 $47.7 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $1.72 Million - $3.33 Million	68,896 Added 14.75%	536,132 $25.9 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $4.08 Million - $8.22 Million	240,540 Added 106.11%	467,236 $13 Million
Q4 2019 Feb 13, 2020	SELL	$24.56 - $32.8 $40,327 - $53,857	-1,642 Reduced 0.72%	226,696 $6.78 Million
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $6.92 Million - $12.2 Million	228,338 New	228,338 $7.06 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Adaptive Biotechnologies Corp Transaction History